share_log

Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9

Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9

Rodman & Renshaw 对奥麦罗制药发起覆盖,给予买入评级,并宣布目标价为9美元。
Benzinga ·  11/14 06:53  · 评级/大行评级

Rodman & Renshaw analyst Brandon Folkes initiates coverage on Omeros (NASDAQ:OMER) with a Buy rating and announces Price Target of $9.

罗德曼和伦肖分析师布兰登·福尔克斯开始对Omeros(纳斯达克股票代码:OMER)进行报道,评级为买入,并宣布目标股价为9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发